← Back to Surgical Precision

THE PERSON BEHIND THE SYSTEM

Alexandros Mallios MD, Chief of Vascular Surgery

Surgeon, innovator and hands-on trader. Bringing observation, imagination and the discipline of learning from experience to AI-assisted trading.

Alexandros Mallios MD
Founder & strategy operator · Surgical Precision

A CAREER IN SURGICAL INNOVATION

Precision built through practice.

Alexandros Mallios is a Greek vascular surgeon and Chief of Vascular Surgery at Centre Hospitalier de Chartres, France. His training took him from Thessaloniki to Paris and a vascular surgery fellowship in Tulsa, USA. His work spans vascular and endovascular surgery, with a particular focus on dialysis access.

He pioneered the first European percutaneous arteriovenous fistula creation using the Ellipsys system and co-founded the Paris Vascular Insights conference. His career combines clinical innovation, international teaching and published research. Read his professional profile in Renal Interventions ↗

His published work explores vascular access, endovascular techniques and new approaches to preserving dialysis access. Explore all publications on PubMed ↗

FROM THE OPERATING ROOM TO THE MARKET

Trial, error—and the discipline to learn.

He began trading as an amateur. Curiosity led to experimentation; mistakes and losses made the need for discipline clear. In a 2021 interview, he was already discussing the challenge of controlling emotion while learning to trade.

Through repeated trial and error, he began applying habits developed in surgery: observe carefully, recognise a changing situation, prepare a response and know when to intervene. Failures became material for review—what happened, why the decision was made and what should change next time.

Surgical Precision grew from that process. Working with AI tools, he translated trading ideas and lessons from experience into programmed rules, coordinated bots and detailed execution logs. AI supports code development, log analysis and proposed improvements; he provides strategic direction, evaluates the findings and approves changes.

The ambition is a continuous learning process: automated execution as the normal mode, careful review of results and human judgment to guide improvements. Manual intervention is reserved for exceptional situations, with the aim of completing disrupted cycles and returning the system to automated trading in line with market conditions.

IN CONVERSATION

Selected interviews.

The importance of prevention

LSI — Life Science Intelligence · 2022

Growth and opportunities — interview with Elsie Koh

LEAD Physician, by Elsie Koh, MD EMHL

Important information & performance methodology

Trading risk & service availability

Leveraged trading involves substantial risk of loss. Past performance does not predict future returns. Hedging changes exposure and can increase gross exposure and margin requirements; it does not erase losses or guarantee recovery. The current system has no hard monetary loss cap. Automated exits require a connected, running terminal with trading enabled, and break-even or profit targets may never be reached.

Manual intervention is intended as an exception to normal automated operation, not a guarantee of recovery or a claim that intervention has been rare in the published history. The current design combines an alternating short-term pair with independent momentum, pullback, bounce, price-level and range models. Recovery and manual basket management apply to designated strategies; independent fixed-stop models retain their own exits. The updated Body engine has recorded its first entry; the broader strategy suite remains under evaluation. This website does not accept deposits, connect subscriber accounts or execute trades. No broker partnership is announced or implied. Proposed pricing, account eligibility, broker arrangements and applicable requirements must be confirmed before launch. The proposed €100 subscriber allocation is not a limit on losses. Subscribers would bear their own gains and losses; the operator trading personal capital does not guarantee subscriber outcomes.

AI-assisted development, surgical experience and close supervision do not establish a profitable trading edge. Reviews depend on submitted logs, with operator approval required before proposed bot changes are implemented.

Understanding the figures

The latest imported MT5 log covers 24 September 2026 at 17:00 through 25 September at 17:39:25, broker time (UTC+3, matching Greek time). This is a historical snapshot, not a live feed. Repeated deal records are deduplicated by broker ticket. Net results include recorded commissions, swaps and fees, and all manual trades in the selected window.

The 15-second models are counted as cycles, from initial entry until their positions close. Automatic recovery legs and the two manual hedges matched by overlapping exposure and simultaneous basket exits are included in the corresponding cycle, rather than counted as separate wins or losses. Other models are counted by closed trade. The Body position remained open at cutoff: its entry cost is included in booked profit, while its floating result remains separate.

The default chart begins at a reference €100 and adds booked net trading profit, excluding deposits, withdrawals and floating P&L. The resulting balance and percentage are calculated on this reference base; they are not the broker account balance or a deposit-adjusted account return. The alternative chart shows actual sampled broker balance and equity.

Account observations begin on 24 September at 18:03. Sampled peak-to-trough equity drawdown in the available heartbeat readings was €52.63; worst sampled floating P&L was -€59.67. Monitoring is incomplete before the first observation, and periodic readings can miss intraperiod extremes.

This window includes changing settings and manual basket management. It is not a test of one fixed configuration or the account’s lifetime record. Reclaim’s seven wins are a small historical sample. Research into entry filters is exploratory and has not established a reliable improvement. The external Myfxbook link is supplementary; the latest figures on this page are calculated from the submitted MT5 log.

Results are from the source account, not subscriber accounts. Copied outcomes may differ because of account size, timing, spreads, commissions and slippage.